DR

Deval Rajnikant Shah

Active Director Whole-Time Director DIN 00332722
DIN 00332722 First appointment Nov 2014 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Past companies 2 historical roles
Total affiliations 4 Since Nov 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Deval Rajnikant Shah

Data last updated:

Deval Rajnikant Shah is a Whole-Time Director at Senores Pharmaceuticals Limited (since 2020) and Non- Individual Subscriber at Senores Foundation (since 2025). The companies operate in Pharma and Engineering. The largest current company by reported revenue is Senores Pharmaceuticals Limited at ₹418 Cr (FY 2025). Earlier, Deval Rajnikant Shah was a Cfo at Sai Consulting Engineers Private Limited (2014–2019) and Director at Ratnagene Lifescience Private Limited (from 2024).

DIN 00332722
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 06 Nov 2014
Oldest Company Age 8 yrs
Largest company Senores Pharmaceuticals Limited Β· ₹418 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Senores Pharmaceuticals Limited L24290GJ2017PLC100263
Whole-Time Director01 Jan 20202017₹418 Cr (FY 2025)Active
Senores Foundation U88900GJ2025NPL169742
Non- Individual Subscriber25 Nov 20252025Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cfo06 Nov 20141983₹104 Cr (FY 2025)Active
Director05 Feb 20242021₹1.98 Cr (FY 2023)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Senores Pharmaceuticals Limited
Ratnagene Lifescience Private Limited
Senores Foundation
Sai Consulting Engineers Private Limited
Premium access

Shareholding and investment profile for Deval Rajnikant Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deval Rajnikant Shah

Deval Rajnikant Shah currently holds 2 directorships: Senores Pharmaceuticals Limited (Whole-Time Director, since 01 Jan 2020, revenue β‚Ή418 Cr (FY 2025)); Senores Foundation (Non- Individual Subscriber, since 25 Nov 2025).

Deval Rajnikant Shah was first appointed on 06 Nov 2014 as Cfo at Sai Consulting Engineers Private Limited. The most recent appointment on record is 25 Nov 2025 at Senores Foundation.

Deval Rajnikant Shah held 2 earlier board appointments: Sai Consulting Engineers Private Limited (Cfo, 06 Nov 2014 to 12 Jun 2019); Ratnagene Lifescience Private Limited (Director, from 05 Feb 2024).

The current boards of Deval Rajnikant Shah's companies include Arpit Deepakkumar Shah (Senores Pharmaceuticals Limited), Ashokkumar Vijaysinh Barot (Senores Pharmaceuticals Limited), Chetan Bipinchandra Shah (Senores Pharmaceuticals Limited), Hemanshu Nitinchandra Pandya (Senores Pharmaceuticals Limited), Jitendra Babulal Sanghvi (Senores Pharmaceuticals Limited), Kalpit Rajesh Gandhi (Senores Pharmaceuticals Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available